Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bodhi Tree Biotechnology (BDTB) FCF Margin (2024 - 2025)

Bodhi Tree Biotechnology (BDTB) has disclosed FCF Margin for 2 consecutive years, with 84.27% as the latest value for Q3 2025.

  • Quarterly FCF Margin changed N/A to 84.27% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1224.39% through Dec 2025, changed N/A year-over-year, with the annual reading at 883.33% for FY2025, N/A changed from the prior year.
  • FCF Margin for Q3 2025 was 84.27% at Bodhi Tree Biotechnology, up from 1305.54% in the prior quarter.
  • The five-year high for FCF Margin was 84.27% in Q3 2025, with the low at 1305.54% in Q4 2024.